Assessment of Usability and Preliminary Effectiveness of a Digital Sleep Aid in an Italian Sample

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversita di Verona

About this trial

Chronic insomnia affects approximately 30% of the Italian population, leading to significant impairments in daily functioning and overall health. While Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended first-line treatment, access is limited due to a shortage of trained specialists and resources within the Italian healthcare system. This study aims to evaluate the usability, acceptability, and preliminary effectiveness of a mobile application designed to assist individuals with chronic insomnia. The app offers digital sleep diaries, personalized sleep hygiene education, relaxation exercises, and an interactive chatbot to promote healthy sleep behaviors. Fifty adult participants diagnosed with chronic insomnia will be randomly assigned to either the intervention group, which will use the mobile application alongside their usual treatment, or to a control group receiving only standard care. The primary outcomes will assess the app's usability and participants' adherence to sleep hygiene practices. Secondary outcomes will evaluate changes in insomnia severity, mood, and quality of life. Assessments will occur at the start of the study, after the 8-week intervention, and at a 6-month follow-up to explore the intervention's long-term effects.

Eligibility criteria

Qualifiers

Adults aged 18 to 70 years

Diagnosis of chronic insomnia according to DSM-5 criteria

Willingness to participate in the study and provide informed consent

Personal active email address

Disqualifiers

Medical conditions requiring hospital admission during the study period

Comorbid diagnosis of sleep-related breathing disorders

Neurological disorders affecting sleep (e.g., narcolepsy, parasomnias, epilepsy, neurodegenerative diseases)

Currently receiving psychological treatment for insomnia or planning to do so within the next 6 months

Trial design

Treatments tested in this trial

  • Digital Health Technology for Chronic Insomnia
  • Treatment as Usual (TAU)

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Universita di Verona

Lead sponsor

Santer Reply S.p.A. Milan, Italy

Collaborator

daVi Digital Medicine s.r.l. Verona, Italy

Collaborator

QStep s.r.l. Verona, Italy

Collaborator

Fondazione RIDE2Med, Milan, Italy

Collaborator